114 related articles for article (PubMed ID: 8061551)
21. Endotoxin stimulates interleukin-6 production in intestinal epithelial cells. A synergistic effect with prostaglandin E2.
Meyer TA; Noguchi Y; Ogle CK; Tiao G; Wang JJ; Fischer JE; Hasselgren PO
Arch Surg; 1994 Dec; 129(12):1290-4; discussion 1294-5. PubMed ID: 7986158
[TBL] [Abstract][Full Text] [Related]
22. Prostaglandin E2 (PGE2) downregulates interleukin (IL)-1alpha-induced IL-6 production via EP2/EP4 subtypes of PGE2 receptors in human periodontal ligament cells.
Noguchi K; Maeda M; Ruwanpura SM; Ishikawa I
Oral Dis; 2005 May; 11(3):157-62. PubMed ID: 15888106
[TBL] [Abstract][Full Text] [Related]
23. Involvement of prostaglandin endoperoxide H synthase-2 in osteoclast-like cell formation induced by interleukin-1 beta.
Sato T; Morita I; Sakaguchi K; Nakahama KI; Smith WL; Dewitt DL; Murota SI
J Bone Miner Res; 1996 Mar; 11(3):392-400. PubMed ID: 8852950
[TBL] [Abstract][Full Text] [Related]
24. Prostaglandin E2 enhances interleukin 8 (IL-8) and IL-6 but inhibits GMCSF production by IL-1 stimulated human synovial fibroblasts in vitro.
Agro A; Langdon C; Smith F; Richards CD
J Rheumatol; 1996 May; 23(5):862-8. PubMed ID: 8724299
[TBL] [Abstract][Full Text] [Related]
25. Bone resorption activity of particulate-stimulated macrophages.
Glant TT; Jacobs JJ; Molnár G; Shanbhag AS; Valyon M; Galante JO
J Bone Miner Res; 1993 Sep; 8(9):1071-9. PubMed ID: 8237476
[TBL] [Abstract][Full Text] [Related]
26. Binary regulation of interleukin (IL)-6 production by EP1 and EP2/EP4 subtypes of PGE2 receptors in IL-1beta-stimulated human gingival fibroblasts.
Noguchi K; Shitashige M; Endo H; Kondo H; Ishikawa I
J Periodontal Res; 2002 Feb; 37(1):29-36. PubMed ID: 11842936
[TBL] [Abstract][Full Text] [Related]
27. Interleukin-1 (IL-1) regulation of human endometrial function: presence of IL-1 receptor correlates with IL-1-stimulated prostaglandin E2 production.
Tabibzadeh S; Kaffka KL; Satyaswaroop PG; Kilian PL
J Clin Endocrinol Metab; 1990 Apr; 70(4):1000-6. PubMed ID: 2138628
[TBL] [Abstract][Full Text] [Related]
28. Menatetrenone inhibits bone resorption partly through inhibition of PGE2 synthesis in vitro.
Hara K; Akiyama Y; Tajima T; Shiraki M
J Bone Miner Res; 1993 May; 8(5):535-42. PubMed ID: 8511981
[TBL] [Abstract][Full Text] [Related]
29. Osteoprotegerin is produced when prostaglandin synthesis is inhibited causing osteoclasts to detach from the surface of mouse parietal bone and attach to the endocranial membrane.
O'Brien EA; Williams JH; Marshall MJ
Bone; 2001 Feb; 28(2):208-14. PubMed ID: 11182380
[TBL] [Abstract][Full Text] [Related]
30. Ascites sarcoma 180, a tumor associated with hypercalcemia, secretes potent bone-resorbing factors including transforming growth factor alpha, interleukin-1 alpha and interleukin-6.
Suzuki K; Yamada S
Bone Miner; 1994 Dec; 27(3):219-33. PubMed ID: 7696888
[TBL] [Abstract][Full Text] [Related]
31. Transforming growth factor-beta stimulates bone resorption in neonatal mouse calvariae by a prostaglandin-unrelated but cell proliferation-dependent pathway.
Lerner UH
J Bone Miner Res; 1996 Nov; 11(11):1628-39. PubMed ID: 8915770
[TBL] [Abstract][Full Text] [Related]
32. Stimulation of neonatal mouse calvarial bone resorption by the glucocorticoids hydrocortisone and dexamethasone.
Conaway HH; Grigorie D; Lerner UH
J Bone Miner Res; 1996 Oct; 11(10):1419-29. PubMed ID: 8889841
[TBL] [Abstract][Full Text] [Related]
33. Integrin subunit beta3 plays a crucial role in the movement of osteoclasts from the periosteum to the bone surface.
Holt I; Marshall MJ
J Cell Physiol; 1998 Apr; 175(1):1-9. PubMed ID: 9491775
[TBL] [Abstract][Full Text] [Related]
34. Evidence for multiple bone resorption-stimulating factors produced by normal human keratinocytes in culture.
Fried RM; Voelkel EF; Rice RH; Levine L; Tashjian AH
Endocrinology; 1988 Jun; 122(6):2467-75. PubMed ID: 2453341
[TBL] [Abstract][Full Text] [Related]
35. Two squamous cell carcinomas not associated with humoral hypercalcemia produce a potent bone resorption-stimulating factor which is interleukin-1 alpha.
Fried RM; Voelkel EF; Rice RH; Levine L; Gaffney EV; Tashjian AH
Endocrinology; 1989 Aug; 125(2):742-51. PubMed ID: 2546747
[TBL] [Abstract][Full Text] [Related]
36. Elevated interleukin 6 is induced by prostaglandin E2 in a murine model of inflammation: possible role of cyclooxygenase-2.
Hinson RM; Williams JA; Shacter E
Proc Natl Acad Sci U S A; 1996 May; 93(10):4885-90. PubMed ID: 8643498
[TBL] [Abstract][Full Text] [Related]
37. Cyclooxygenase-2-dependent prostaglandin (PG) E2 downregulates matrix metalloproteinase-3 production via EP2/EP4 subtypes of PGE2 receptors in human periodontal ligament cells stimulated with interleukin-1alpha.
Yan M; Noguchi K; Ruwanpura SM; Ishikawa I
J Periodontol; 2005 Jun; 76(6):929-35. PubMed ID: 15948687
[TBL] [Abstract][Full Text] [Related]
38. Cyclooxygenase-2 inhibitors decrease interleukin-1beta-stimulated prostaglandin E2 and IL-6 production by human gingival fibroblasts.
Tipton DA; Flynn JC; Stein SH; Dabbous MKh
J Periodontol; 2003 Dec; 74(12):1754-63. PubMed ID: 14974816
[TBL] [Abstract][Full Text] [Related]
39. Tumor necrosis factor-alpha (cachectin) stimulates bone resorption in mouse calvaria via a prostaglandin-mediated mechanism.
Tashjian AH; Voelkel EF; Lazzaro M; Goad D; Bosma T; Levine L
Endocrinology; 1987 May; 120(5):2029-36. PubMed ID: 3106013
[TBL] [Abstract][Full Text] [Related]
40. Comparative study of the endotoxemia and endotoxin tolerance on the production of Th cytokines and macrophage interleukin-6: differential regulation of indomethacin.
Chae BS
Arch Pharm Res; 2002 Dec; 25(6):910-6. PubMed ID: 12510847
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
